Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (year values)

2019 2020 2021 2022 2023   LTM ?
Debt/EBITDA 1.78 0.81 -0.01 -0.42 -0.92   -2.55
Changes by years, y/y, % 0% -55% -101% +4 630% +122%    

Heron Therapeutics. Debt/EBITDA

Heron Therapeutics. Debt/EBITDA, changes, %

Heron Therapeutics (HRTX) Debt/EBITDA US GAAP (quarter values)

2023Q2 2023Q3 2023Q4 2024Q1 2024Q2   LTM ?
Debt/EBITDA -0.91 -0.87 -0.92 -1.35 -2.55   -2.55
Changes by years, y/y, % +165% +397% +119% +99% +182%    
Changes by quarters, q/q, % +34% -5% +6% +47% +89%    

Heron Therapeutics. Debt/EBITDA

Heron Therapeutics. Debt/EBITDA, changes, y/y, %

Heron Therapeutics. Debt/EBITDA, changes, q/q, %